Meanwhile, under the treatment of RSL3, the results of flow cytometry analysis displayed that the K383 deacetylation of ACSL4 could inhibit the lip-ROS level of NPC cells (Fig. 9B). This evidence concerns the gene ACSL4 and nasopharyngeal carcinoma.